Becton Dickinson & Co

Company facts

Industry

Surgical & Medical Instruments & Apparatus

Headquarters

Franklin Lakes, New Jersey

Most recent report

10-Q, filed Aug 6, 2026

Incorporated

New Jersey

Filings on record

1,000+ filings

On EDGAR

CIK 10795

Fiscal year ends

September

Filer status

Large accelerated filer

What to read: Jun 2026 10-Q

SECSift found 3 of 12 sections worth reading, with 2 positive, 5 notable, and 4 negative flags.

• Item 1

  Core financials post-spin-off; revenue up but operating income down; large buyback and debt paydown; $1.6B litigation accrual; FDA warning letters.
  Notable

  • Spin-off provided $4B cash; $2B used for buyback and $2B for debt paydown.
  Negative

  • El Paso FDA Warning Letter: charges recorded in Q3, voluntary ship hold on ChloraPrep/PurPrep.
  • Litigation accruals stood at $1.6B at June 30, 2026.

• Item 2

  New FDA warning letter, spin-off effects, $450M impairment, tariffs hitting margins.
  Positive

  • Revenue grew 5.4% to $4.983B in Q3 2026, driven by 4.1% volume growth and favorable FX.
  • First nine months FY2026 operating cash flow was $2.104B, up from $1.578B in prior year.
  Notable

  • Repurchased $2.250B of common stock in first nine months FY2026, funded partly by $4B spin-off distribution.
  • Recorded $450M non-cash asset impairment in Q2 2026 from exiting projects under 'Excellence Unleashed' strategy.
  Negative

  • Tariffs hit operating expenses in Q3 2026; expected continued adverse impact for FY2026 and beyond.
  • New El Paso Warning Letter (Apr 30, 2026) may lead to product seizures or consent decree; liability recorded.

• Unregistered Sales and Repurchases (Item 2)

  Large ASR settlement and program utilization; shareholder return details matter.
  Notable

  • Authorization from January 2025 fully used in May 2026; new Jan 2026 program has 8.3 million shares remaining.
  • Final settlement of $2 billion ASR added 3.2 million shares in May 2026 at ~$125/share, completing the February 2026 deal.

What changed: Jun 2026 vs. Mar 2026

About 6% of BDX's Jun 2026 10-Q is new information. 21 paragraphs were added, 207 changed, and 58 removed. Below are the most important lines SECSift identified.

• Item 2 103
• Item 1 67
• Item 4 2
• Item 5 2